References
- 1Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021; 71(1): 7–33. DOI: 10.3322/caac.21654
- 2Koopmann B, Omidvari AH, Lansdorp-Vogelaar I, Cahen DL, Bruno MJ, de Kok I. The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies. Int J Cancer. 2023; 152(8): 1570–1580. DOI: 10.1002/ijc.34379
- 3McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018; 24(43): 4846–4861. DOI: 10.3748/wjg.v24.i43.4846
- 4Sun D, Cao M, Li H, He S, Chen W. Cancer burden and trends in China: A review and comparison with Japan and South Korea. Chin J Cancer Res. 2020; 32(2): 129–139. DOI: 10.21147/j.issn.1000-9604.2020.02.01
- 5Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3): 209–249. DOI: 10.3322/caac.21660
- 6Maisonneuve P. Epidemiology and burden of pancreatic cancer. Presse Med. 2019; 48(3 Pt 2): e113–113e123. DOI: 10.1016/j.lpm.2019.02.030
- 7Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2019; 5(12): 1749–1768. DOI: 10.1001/jamaoncol.2019.2996
- 8GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 1204–1222. DOI: 10.1016/S0140-6736(20)30925-9
- 9GBD 2019 Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 1135–1159. DOI: 10.1016/S0140-6736(20)31404-5
- 10Tian H, Zhang K, Hui Z, et al. Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019. Clin Res Hepatol Gastroenterol. 2023; 47(1):
102068 . DOI: 10.1016/j.clinre.2022.102068 - 11Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. DOI: 10.3322/caac.21492
- 12Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 7–30. DOI: 10.3322/caac.21590
- 13Zhu B, Wu X, Guo T, Guan N, Liu Y. Epidemiological characteristics of pancreatic cancer in China from 1990 to 2019. Cancer Control. 2021; 28: 10732748211051536. DOI: 10.1177/10732748211051536
- 14Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research. 2014; 74(11): 2913–2921. DOI: 10.1158/0008-5472.CAN-14-0155
- 15Ilic M, Ilic I. Epidemiology of pancreatic cancer. World journal of gastroenterology. 2016; 22(44): 9694–705. DOI: 10.3748/wjg.v22.i44.9694
- 16Veisani Y, Jenabi E, Khazaei S, Nematollahi S. Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach. Public Health. 2018; 156: 87–91. DOI: 10.1016/j.puhe.2017.12.015
- 17Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009; 170(4): 403–413. DOI: 10.1093/aje/kwp134
- 18Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010; 170(9): 791–802. DOI: 10.1001/archinternmed.2010.63
- 19Koyanagi YN, Ito H, Matsuo K, et al. Smoking and pancreatic cancer incidence: A pooled analysis of 10 population-based cohort studies in Japan. Cancer Epidemiol Biomarkers Prev. 2019; 28(8): 1370–1378. DOI: 10.1158/1055-9965.EPI-18-1327
- 20Molina-Montes E, Van Hoogstraten L, Gomez-Rubio P, et al. Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships. Cancer Epidemiol Biomarkers Prev. 2020; 29(5): 1009–1018. DOI: 10.1158/1055-9965.EPI-19-1027
- 21Weissman S, Takakura K, Eibl G, Pandol SJ, Saruta M. The diverse involvement of cigarette smoking in pancreatic cancer development and prognosis. Pancreas. 2020; 49(5): 612–620. DOI: 10.1097/MPA.0000000000001550
- 22ALHarthi S, Natto ZS, Midle JB, Gyurko R, O’Neill R, Steffensen B. Association between time since quitting smoking and periodontitis in former smokers in the National Health and Nutrition Examination Surveys (NHANES) 2009 to 2012. J Periodontol. 2019; 90(1): 16–25. DOI: 10.1002/JPER.18-0183
- 23Ben QW, Liu J, Sun YW, Wang LF, Zou DW, Yuan YZ. Cigarette smoking and mortality in patients with pancreatic cancer: A systematic review and meta-analysis. Pancreas. 2019; 48(8): 985–995. DOI: 10.1097/MPA.0000000000001383
- 24Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008; 393(4): 535–545. DOI: 10.1007/s00423-007-0266-2
- 25Chen Z, Peto R, Zhou M, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet. 2015; 386(10002): 1447–1456. DOI: 10.1016/S0140-6736(15)00340-2
- 26Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer. 2011; 47(13): 1928–1937. DOI: 10.1016/j.ejca.2011.03.003
- 27Batabyal P, Vander Hoorn S, Christophi C, Nikfarjam M. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Anns Surg Oncol. 2014; 21(7): 2453–2462. DOI: 10.1245/s10434-014-3625-6
- 28Andersen DK, Korc M, Petersen GM, et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes. 2017; 66(5): 1103–1110. DOI: 10.2337/db16-1477
- 29Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: Opportunities and challenges. Gastroenterology. 2019; 156(7): 2024–2040. DOI: 10.1053/j.gastro.2019.01.259
- 30Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control. 2011; 22(2): 189–197. DOI: 10.1007/s10552-010-9686-3
- 31Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020; (360): 1–8.
- 32Preziosi G, Oben JA, Fusai G. Obesity and pancreatic cancer. Surg Oncol. 2014;23(2):61–71. DOI: 10.1016/j.suronc.2014.02.003
- 33Jiao L, Chen L, White DL, et al. Low-fat dietary pattern and pancreatic cancer risk in the Women’s Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2018; 110(1). DOI: 10.1093/jnci/djx117
